Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Cost Effectiveness Analysis In CER: Perhaps Not So Controversial After All?
Jun 11 2012
•
By
Gregory Twachtman
More from Archive
More from Pink Sheet